A Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Olea Europaea and Phleum Pratense

NCT02849249 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinoconjuntivitis

Interventions

BIOLOGICAL: allergovac polimerized (100/100)

Sponsor

Roxall Medicina España S.A